DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
8.11
-0.34 (-4.02%)
At close: Mar 27, 2026, 4:00 PM EDT
8.42
+0.31 (3.82%)
After-hours: Mar 27, 2026, 4:04 PM EDT

DarioHealth Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
22.3627.0420.3527.6620.51
Revenue Growth (YoY)
-17.31%32.86%-26.41%34.82%170.76%
Cost of Revenue
9.6913.7714.371816.55
Gross Profit
12.6713.275.989.663.96
Selling, General & Admin
35.5346.8341.9346.8263.24
Research & Development
13.7924.1820.2519.6517.22
Total Operating Expenses
49.3271.0162.1766.4780.46
Operating Income
-36.66-57.74-56.19-56.81-76.49
Interest Expense
-3.02----
Other Non-Operating Income (Expense)
-6.8926.29-3.17-5.38-0.24
Total Non-Operating Income (Expense)
-9.9126.29-3.17-5.38-0.24
Pretax Income
-41.61-44.6-59.36-62.19-76.73
Provision for Income Taxes
0.11-1.850.0600.03
Net Income
-61.74-40.98-63.51-63.84-78.77
Net Income Attributable to Preferred Dividends
20.02-1.774.081.642.01
Net Income to Common
-61.74-40.98-63.51-63.84-78.77
Shares Outstanding (Basic)
42111
Shares Outstanding (Diluted)
42111
Shares Change (YoY)
62.44%72.84%20.04%59.18%148.99%
EPS (Basic)
10.1212.27-38.60-50.80-71.60
EPS (Diluted)
10.1212.27-38.60-50.80-71.60
EPS Growth
-17.52%----
Free Cash Flow
15.634.05-30.96-48.29-50.67
Free Cash Flow Growth
286.24%----
Free Cash Flow Per Share
3.921.65-21.83-40.86-68.25
Gross Margin
56.64%49.06%29.40%34.91%19.32%
Operating Margin
-163.94%-213.55%-276.09%-205.42%-372.90%
Profit Margin
-186.56%-158.09%-292.00%-224.88%-374.21%
FCF Margin
69.91%14.97%-152.14%-174.60%-247.01%
EBITDA
-33.52-50.32-51.2-52.09-72.04
EBITDA Margin
-149.90%-186.08%-251.59%-188.36%-351.18%
EBIT
-36.66-57.74-56.19-56.81-76.49
EBIT Margin
-163.94%-213.55%-276.09%-205.42%-372.90%
Effective Tax Rate
-0.25%4.15%-0.11%-0.01%-0.04%
Updated Mar 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q